Therapeutic Effects of Stimulating the Melanocortin Pathway in Regulating Ocular Inflammation and Cell Death

Shudan Wang,Francesca Kahale,Amirreza Naderi,Pier Luigi Surico,Jia Yin,Thomas Dohlman,Yihe Chen,Reza Dana
DOI: https://doi.org/10.3390/biom14020169
IF: 6.064
2024-01-31
Biomolecules
Abstract:Alpha-melanocyte-stimulating hormone (α-MSH) and its binding receptors (the melanocortin receptors) play important roles in maintaining ocular tissue integrity and immune homeostasis. Particularly extensive studies have demonstrated the biological functions of α-MSH in both immunoregulation and cyto-protection. This review summarizes the current knowledge of both the physiological and pathological roles of α-MSH and its receptors in the eye. We focus on recent developments in the biology of α-MSH and the relevant clinical implications in treating ocular diseases.
biochemistry & molecular biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the therapeutic effects of stimulating the melanocortin pathway (through α - MSH and its receptors) in regulating ocular inflammation and cell death. Specifically, the paper summarizes the current knowledge about the physiological and pathological roles of α - MSH and its receptors in the eye, and focuses on the latest progress of α - MSH in the treatment of ocular diseases. ### Main problems of the paper 1. **The role of α - MSH in the eye**: - The important roles of α - MSH and its receptors in maintaining the integrity of ocular tissues and immune homeostasis. - The biological functions of α - MSH in immunomodulation and cell protection. 2. **Regulation of ocular inflammation and cell death**: - The role of α - MSH in reducing ocular inflammation and promoting the survival of corneal surface cells. - The specific mechanisms by which α - MSH exerts its anti - inflammatory and cell - protective effects by activating different melanocortin receptors (MC1R, MC3R, MC4R, MC5R). 3. **Clinical application prospects**: - The potential applications of α - MSH and its receptor agonists in the treatment of ocular diseases, especially in relieving inflammation caused by surgery, trauma, infection or autoimmunity. - Whether α - MSH can effectively reduce ocular inflammation and cell damage through local or systemic administration, thereby preventing or treating blinding diseases such as corneal opacity and vascularization. ### Main research contents - **The bioavailability of α - MSH**: - The expression and production of α - MSH in different ocular tissues, such as retinal pigment epithelial cells (RPE), ciliary body epithelial cells, iris pigment epithelial cells, vitreous cells and macrophages. - The concentration of α - MSH in aqueous humor and its regulatory effect on T - cell activity. - **The cell - protective effect of α - MSH**: - The protective effect of α - MSH in inhibiting cytotoxic signals and apoptosis - inducing signals. - The functions of α - MSH in nerve injury repair, antioxidant stress, and inhibition of inflammatory mediator production. - **The regenerative effect of α - MSH**: - The role of α - MSH in promoting the migration and proliferation of corneal endothelial cells, accelerating wound healing and endothelial regeneration. - **The anti - inflammatory effect of α - MSH**: - The role of α - MSH in inhibiting the expression of pro - inflammatory cytokines and adhesion molecules in multiple cell types. - The role of α - MSH in inducing the generation of regulatory T cells (Tregs) and inhibiting the activation of effector T cells. - **The anti - angiogenic effect of α - MSH**: - The role of α - MSH in inhibiting corneal neovascularization through NO deficiency and inhibition of the VEGF/VEGFR2/Akt signaling pathway. ### Conclusion By reviewing the roles of α - MSH and its receptors in ocular inflammation and cell death, this paper shows the great potential of α - MSH in the treatment of ocular diseases, especially in reducing inflammation and promoting cell survival through local administration. These findings provide a theoretical basis for further development of α - MSH - based treatment methods.